Collection

Clinical Presentations

Clinical Data
Visual Acuity and Lesion Size at Diagnosis of Wet AMD

Lesions at the onset of wet AMD grow more quickly, resulting in more rapid vision loss than later stage lesions. Vision is better preserved when anti-VEGF therapy is initiated while wet AMD lesions are small, and visual acuity has not yet deteriorated.​

Clinical Data
Clinical Trial and Real-World Data Show Small Proportion of Patients with Good VA at Initiation of Anti-VEGF Therapy

View the real-world and clinical trial data, which shows that early wet AMD diagnosis with good visual acuity is essential in preserving long-term functional vision (20/40 or better) with treatment.

Clinical Data
AMD Standard of Care is Not Enough

Early diagnosis with good visual acuity (VA) is essential to preserve functional vision with anti-VEGF therapy, but only a third of eyes are diagnosed at 20/40 or better.

Clinical Data
ForeseeHome Helps Physicians Detect Wet AMD Earlier

The HOME study showed that ForeseeHome is superior in helping to detect conversion in eyes with good vision over standard of care alone. Patient compliance in the real world is excellent, largely because of the patient engagement the Notal Vision Monitoring Center provides.